
### [MONDO:0017740](http://purl.obolibrary.org/obo/MONDO_0017740)
**Label:** disorder of protein N-glycosylation

**Subclasses:** [MONDO:0012117](http://purl.obolibrary.org/obo/MONDO_0012117) (ALG9-CDG), [MONDO:0018144](http://purl.obolibrary.org/obo/MONDO_0018144) (congenital myasthenic syndromes with glycosylation defect), 

**Corr. equiv. classes:** [Orphanet:79328](http://www.orpha.net/ORDO/Orphanet_79328), [OMIM:614750](http://purl.obolibrary.org/obo/OMIM_614750), [OMIM:608776](http://purl.obolibrary.org/obo/OMIM_608776), [OMIM:610542](http://purl.obolibrary.org/obo/OMIM_610542), [OMIM:616228](http://purl.obolibrary.org/obo/OMIM_616228), [OMIM:616227](http://purl.obolibrary.org/obo/OMIM_616227), [OMIM:263210](http://purl.obolibrary.org/obo/OMIM_263210), [Orphanet:353327](http://www.orpha.net/ORDO/Orphanet_353327), 

**Class expressions from DL-Learner:**

- [HP:0003473](http://purl.obolibrary.org/obo/HP_0003473) (Fatigable weakness) and [HP:0008180](http://purl.obolibrary.org/obo/HP_0008180) (Mildly elevated creatine phosphokinase) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 62.50%
- [HP:0003473](http://purl.obolibrary.org/obo/HP_0003473) (Fatigable weakness) and [HP:0008180](http://purl.obolibrary.org/obo/HP_0008180) (Mildly elevated creatine phosphokinase) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 62.50%
- [HP:0001270](http://purl.obolibrary.org/obo/HP_0001270) (Motor delay) and [HP:0003473](http://purl.obolibrary.org/obo/HP_0003473) (Fatigable weakness) and [HP:0008180](http://purl.obolibrary.org/obo/HP_0008180) (Mildly elevated creatine phosphokinase) 62.50%
- [HP:0003391](http://purl.obolibrary.org/obo/HP_0003391) (Gowers sign) and [HP:0003473](http://purl.obolibrary.org/obo/HP_0003473) (Fatigable weakness) and [HP:0008180](http://purl.obolibrary.org/obo/HP_0008180) (Mildly elevated creatine phosphokinase) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 62.50%
- [HP:0003391](http://purl.obolibrary.org/obo/HP_0003391) (Gowers sign) and [HP:0003473](http://purl.obolibrary.org/obo/HP_0003473) (Fatigable weakness) and [HP:0008180](http://purl.obolibrary.org/obo/HP_0008180) (Mildly elevated creatine phosphokinase) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 62.50%
- [HP:0002515](http://purl.obolibrary.org/obo/HP_0002515) (Waddling gait) and [HP:0003473](http://purl.obolibrary.org/obo/HP_0003473) (Fatigable weakness) and [HP:0008180](http://purl.obolibrary.org/obo/HP_0008180) (Mildly elevated creatine phosphokinase) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 62.50%
- [HP:0002515](http://purl.obolibrary.org/obo/HP_0002515) (Waddling gait) and [HP:0003473](http://purl.obolibrary.org/obo/HP_0003473) (Fatigable weakness) and [HP:0008180](http://purl.obolibrary.org/obo/HP_0008180) (Mildly elevated creatine phosphokinase) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 62.50%
- [HP:0001288](http://purl.obolibrary.org/obo/HP_0001288) (Gait disturbance) and [HP:0003473](http://purl.obolibrary.org/obo/HP_0003473) (Fatigable weakness) and [HP:0008180](http://purl.obolibrary.org/obo/HP_0008180) (Mildly elevated creatine phosphokinase) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 62.50%
- [HP:0001288](http://purl.obolibrary.org/obo/HP_0001288) (Gait disturbance) and [HP:0003473](http://purl.obolibrary.org/obo/HP_0003473) (Fatigable weakness) and [HP:0008180](http://purl.obolibrary.org/obo/HP_0008180) (Mildly elevated creatine phosphokinase) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) 62.50%
- [HP:0001270](http://purl.obolibrary.org/obo/HP_0001270) (Motor delay) and [HP:0003391](http://purl.obolibrary.org/obo/HP_0003391) (Gowers sign) and [HP:0003473](http://purl.obolibrary.org/obo/HP_0003473) (Fatigable weakness) and [HP:0008180](http://purl.obolibrary.org/obo/HP_0008180) (Mildly elevated creatine phosphokinase) 62.50%
- [HP:0001270](http://purl.obolibrary.org/obo/HP_0001270) (Motor delay) and [HP:0002515](http://purl.obolibrary.org/obo/HP_0002515) (Waddling gait) and [HP:0003473](http://purl.obolibrary.org/obo/HP_0003473) (Fatigable weakness) and [HP:0008180](http://purl.obolibrary.org/obo/HP_0008180) (Mildly elevated creatine phosphokinase) 62.50%
- [HP:0001270](http://purl.obolibrary.org/obo/HP_0001270) (Motor delay) and [HP:0001288](http://purl.obolibrary.org/obo/HP_0001288) (Gait disturbance) and [HP:0003473](http://purl.obolibrary.org/obo/HP_0003473) (Fatigable weakness) and [HP:0008180](http://purl.obolibrary.org/obo/HP_0008180) (Mildly elevated creatine phosphokinase) 62.50%
- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0003473](http://purl.obolibrary.org/obo/HP_0003473) (Fatigable weakness) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 62.50%
- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0003473](http://purl.obolibrary.org/obo/HP_0003473) (Fatigable weakness) and [HP:0012758](http://purl.obolibrary.org/obo/HP_0012758) (Neurodevelopmental delay) and [HP:0040081](http://purl.obolibrary.org/obo/HP_0040081) (Abnormal levels of creatine kinase in blood) 62.50%
- [HP:0000271](http://purl.obolibrary.org/obo/HP_0000271) (Abnormality of the face) and [HP:0003473](http://purl.obolibrary.org/obo/HP_0003473) (Fatigable weakness) and [HP:0008180](http://purl.obolibrary.org/obo/HP_0008180) (Mildly elevated creatine phosphokinase) and [HP:0012759](http://purl.obolibrary.org/obo/HP_0012759) (Neurodevelopmental abnormality) 62.50%


